Boehringer Ingelheim And Ecron Acunova Think Regionally For Clinical Trials – Bangalore Bio
This article was originally published in PharmAsia News
Executive Summary
Boehringer sees advantages to a long-term, and expansive CRO partnership instead of carving up markets in Asia.